Souvignier conducts the scientific and business analysis of early-stage biomedical investment opportunities for RCT and also manages a portfolio of projects and investments for RCT. His areas of focus at RCT include oncology, pain, central nervous system disorders, diabetes and metabolic disease.

Contact Support
Need help? We're here for you. Contact us anytime using the information below.
800-553-0977 or 215-253-5777
support@halolabs.com